Global & Public Health (all articles)
The emergence of SARS-CoV-2 in Europe and North America
11 Sep, 2020 | 01:48h | UTCThe emergence of SARS-CoV-2 in Europe and North America – Science
Commentary: How coronavirus took hold in North America and in Europe – University of Arizona
Commentary on Twitter
"Our analyses … show that intensive testing and contact tracing could have prevented #SARSCoV2 from becoming established" in the United States and Europe
Just published @ScienceMagazine https://t.co/ywVKe3YteI @LemeyLab and collaborators pic.twitter.com/7AaB7Z7TeJ— Eric Topol (@EricTopol) September 10, 2020
Cochrane evidence on COVID-19: a round-up
11 Sep, 2020 | 01:47h | UTCCochrane evidence on COVID-19: a round-up – Evidently Cochrane
[Preprint] Transmission dynamics of COVID-19 in household and community settings in the United Kingdom
11 Sep, 2020 | 01:45h | UTC
Commentary on Twitter
Estimate of 37% (95% CI: 31-43%) secondary attack rate within UK households during early stages of pandemic (i.e. probability of transmission between first case and each household contact) https://t.co/rUTP70cbuA via @sbfnk pic.twitter.com/H8HjNku62F
— Adam Kucharski (@adamjkucharski) September 10, 2020
The lessons we’ve learned from the Covid-19 response, according to Anthony Fauci
11 Sep, 2020 | 01:40h | UTCThe lessons we’ve learned from the Covid-19 response, according to Anthony Fauci – STAT
Commentary on Twitter
Fauci's lessons learned on Covid-19, in short:
* Never underestimate the potential impact of an outbreak.
* Scientifically sound research matters.
* Adapt to new information
* It's past time to address health care disparities.https://t.co/Ju7vm6iOQg— Jason Ukman (@JasonUkman) September 10, 2020
Editorial: Reassuring the public and clinical community about the scientific review and approval of a COVID-19 vaccine
11 Sep, 2020 | 01:33h | UTC
Perspective: Fairly prioritizing groups for access to COVID-19 vaccines
11 Sep, 2020 | 01:34h | UTCFairly Prioritizing Groups for Access to COVID-19 Vaccines – JAMA
UNICEF/WHO: COVID-19 could reverse decades of progress toward eliminating preventable child deaths, agencies warn
11 Sep, 2020 | 01:31h | UTC
Audio interview: Guidelines for Covid-19 vaccine deployment
11 Sep, 2020 | 01:29h | UTCAudio Interview: Guidelines for Covid-19 Vaccine Deployment – New England Journal of Medicine
The underdog coronavirus vaccines that the world will need if front runners stumble
11 Sep, 2020 | 01:20h | UTCThe underdog coronavirus vaccines that the world will need if front runners stumble – Nature
New easy-to-use score for predicting risk of death in patients hospitalized with Covid-19
10 Sep, 2020 | 09:51h | UTCCommentaries: Discovery of four COVID-19 risk groups helps guide treatment – University of Edinburgh AND Expert reaction to a study looking at predicting the risk of death in hospitalised COVID-19 patients – Science Media Centre
Commentary on Twitter
NEW #BMJResearch finds that an easy-to-use score for predicting risk of death in adult patients admitted to hospital with #COVID19 outperforms existing scores and can be used to support treatment decisions @ProfCalumSemple @ISARIC1
https://t.co/2J9S3mqG5h— The BMJ (@bmj_latest) September 10, 2020
Why COVID-19 is more deadly in people with obesity—even if they’re young
10 Sep, 2020 | 09:47h | UTCWhy COVID-19 is more deadly in people with obesity—even if they’re young – Science
Clinical outcomes in young adults hospitalized with COVID-19
10 Sep, 2020 | 09:49h | UTCClinical Outcomes in Young US Adults Hospitalized With COVID-19 – JAMA Internal Medicine
Editorial: Regardless of Age, Obesity and Hypertension Increase Risks With COVID-19
Commentary: Obesity greatest risk factor for young adults with COVID-19 – MedicalXpress
Commentary on Twitter
18 to 34 years old #COVID19 hospitalized outcomes:
✔️21% intensive care,
✔️10% mechanical ventilation
✔️2.7% died.
✔️Morbid obesity, hypertension & diabetes associated with⬆️risks of adverse events.
✔️+ ½ requiring hospitalization: Black or Hispanic⚓️https://t.co/kcs2cery7s pic.twitter.com/ASVB943Bhc
— Medtorek (@Medtorek) September 9, 2020
Study: Kids with COVID-19, flu equally prone to severe illness
10 Sep, 2020 | 09:45h | UTCKids with COVID-19, flu equally prone to severe illness – CIDRAP
Original study: Comparison of Clinical Features of COVID-19 vs Seasonal Influenza A and B in US Children – JAMA Network Open
Commentary on Twitter
A study comparing 315 children with #COVID19 and 1402 children with seasonal #influenza showed no statistically significant differences in hospitalization rates, hospitalization in intensive care and use of mechanical ventilators between the 2 groups.https://t.co/jLW9IHEuxi
— Cristina Dragani (@CristinaDragani) September 9, 2020
Opinion: Halting the Oxford vaccine trial doesn’t mean it’s not safe – it shows they’re following the right process
10 Sep, 2020 | 09:42h | UTC
A leading coronavirus vaccine trial is on hold: Scientists react
10 Sep, 2020 | 09:43h | UTCA leading coronavirus vaccine trial is on hold: scientists react – Nature
‘Everyone was left to guess what went wrong’: An open letter to AstraZeneca’s CEO on transparency
10 Sep, 2020 | 09:40h | UTC
Commentary on Twitter
Opinion: "In the middle of a pandemic — when the whole world, literally, is hoping a useful vaccine is on the horizon — everyone was left to guess what went wrong and what it might mean," @Pharmalot writes. https://t.co/jOpMyxC1dQ
— STAT (@statnews) September 9, 2020
Characteristics, comorbidities, and outcomes in a multicenter registry of patients with HIV and Covid-19
10 Sep, 2020 | 09:38h | UTC
Commentary on Twitter
🔥REDCap Data 🔥
A new multicenter registry
Severe clinical outcomes occurred commonly in people with HIV& #COVID19
The risk for poor outcomes was higher in those with comorbidities & lower CD4 cell counts, despite HIV viral suppression. @dr_dimadandachi https://t.co/Mg9lZgYxZy pic.twitter.com/GhBAD2ynqs— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) September 9, 2020
WHO calls for global action on sepsis – cause of 1 in 5 deaths worldwide
10 Sep, 2020 | 09:27h | UTCWHO calls for global action on sepsis – cause of 1 in 5 deaths worldwide – World Health Organization
Report: Global report on the epidemiology and burden of sepsis – World Health Organization
Commentary on Twitter
Today the first Global report on #sepsis was launched, offering the most comprehensive evidence on the life-threatening condition
👉 https://t.co/sSLSPAQFv8 pic.twitter.com/iCv4n2Ux9n
— World Health Organization (WHO) (@WHO) September 9, 2020
WHO: More than 3 billion people protected from harmful trans-fat in their food
10 Sep, 2020 | 09:25h | UTCReport: Countdown to 2023: WHO report on global trans-fat elimination 2020 – World Health Organization
Commentary on Twitter
More than 3⃣ billion people across 5⃣8⃣ countries are now protected from harmful trans-fat in their food since the launch of WHO’s global #REPLACEtransfat initiative.
More details 👉https://t.co/3E5NIo8Y9Z #BeatNCDs pic.twitter.com/OHevkpBgaj
— World Health Organization (WHO) (@WHO) September 9, 2020
Opinion: “Facial masking for Covid-19 — potential for “variolation” as we await a vaccine”
9 Sep, 2020 | 09:39h | UTC
Commentary on Twitter
Increasing the proportion of SARS-CoV-2 infections that are asymptomatic with the simple public health measure of universal masking might help make the infection less deadly and increase population-level immunity without severe illnesses and deaths. #COVID19 #SARSCoV2
— NEJM (@NEJM) September 8, 2020
AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K.
9 Sep, 2020 | 09:45h | UTC
Commentary on Twitter
BREAKING: AstraZeneca's #Covid19 vaccine trials have been paused as the company investigates a serious adverse event the occurred in the UK. Not clear if the unexplained illness is linked to the vaccine, or what it was. https://t.co/wGqvvXIBTD
— Helen Branswell 🇨🇦 (@HelenBranswell) September 8, 2020
Drug companies seek to reassure the public about Covid-19 vaccine safety
9 Sep, 2020 | 09:43h | UTCSee also: 9 Drugmakers Sign Safety Pledge In Rush To Develop Coronavirus Vaccine – NPR AND U.S., European COVID-19 vaccine developers pledge to uphold testing rigour – Reuters
The coronavirus is mutating — does it matter?
9 Sep, 2020 | 09:35h | UTCThe coronavirus is mutating — does it matter? – Nature
IDSA Podcast: The global health impact of COVID-19
9 Sep, 2020 | 09:26h | UTCThe Global Health Impact of COVID-19 – Infectious Diseases Society of America
Commentary on Twitter
NEW PODCAST 🎙️ "The Global Health Impact of COVID-19"
Listen: https://t.co/Su7sJNq8CZ @CDCgov global health experts Dr. Barbara Marston & Dr. Nancy Knight join us to discuss the agency’s role in responding to the COVID-19 pandemic globally. @CDCGlobal pic.twitter.com/NowVQ301xU
— IDSA (@IDSAInfo) September 8, 2020
Perspective: “When will WE have a vaccine?” — understanding questions and answers about Covid-19 vaccination
9 Sep, 2020 | 09:37h | UTC
Commentary on Twitter
People inquiring about Covid-19 vaccines often want to know when the public can be confident that available vaccines are safe and effective, when a vaccine will be available to people like them, and when uptake will be high enough to enable a return to prepandemic life. #COVID19
— NEJM (@NEJM) September 8, 2020